Activated Leukocyte Cell Adhesion Molecule (ALCAM) Expression is Associated with a Poor Prognosis for Bladder Cancer Patients

References

• Jemal A Murray T Samuels A Ghafoor A Ward E Thun MJ 2003 Cancer Statistics. 2003 CA Cancer J. Clin. 5 26
   Google Scholar
• Raghavan , D , Shipley , WU , Garnick , MB , Russell , PJ and Richie , JP . 1990 . Biology and management of bladder cancer . N. Engl. J. Med. , 322 : 1129 – 1138 .
   PubMed Web of Science ®Google Scholar
• Heney , NM , Ahmed , S , Flanagan , MJ , Frable , W , Corder , MP , Hafermann , MD and Hawkins , IR . 1983 . Superficial bladder cancer: progression and recurrence . J. Urol. , 130 : 1083 – 1086 .
   PubMed Web of Science ®Google Scholar
• Kiemeney , LA , Witjes , JA , Heijbroek , RP , Verbeek , AL and Debruyne , FM . 1993 . Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer . J. Urol. , 150 : 60 – 64 .
   PubMed Web of Science ®Google Scholar
• Badalament , RA , Ortolano , V and Burgers , JK . 1992 . Recurrent or aggressive bladder cancer. Indications for adjuvant intravesical therapy . Urol. Clin. North Am. , 19 : 485 – 498 .
   PubMedGoogle Scholar
• Bassi , P , Ferrante , GD , Piazza , N , Spinadin , R , Carando , R , Pappagallo , G and Pagano , F . 1999 . Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort . J. Urol. , 161 : 1494 – 1497 .
   PubMed Web of Science ®Google Scholar
• Vieweg , J , Whitmore , WF Jr. , Herr , HW , Sogani , PC , Russo , P , Sheinfeld , J and Fair , WR . 1994 . The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The memorial sloan-kettering cancer center experience . Cancer , 73 : 3020 – 3028 .
   PubMedGoogle Scholar
• Malmstrom , PU , Busch , C and Norlen , BJ . 1987 . Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up . Scand. J. Urol. Nephrol. , 21 : 185 – 195 .
   PubMed Web of Science ®Google Scholar
• Yaman , O , Baltaci , S , Arikan , N , Yilmaz , E and Gogus , O . 1996 . Staging with computed tomography, transrectal ultrasonography and transurethral resection of bladder tumor: comparison with final pathological stage in invasive bladder carcinoma . Br. J. Urol. , 78 : 197 – 200 .
   PubMedGoogle Scholar
• Lipponen , PK . 1992 . Review of cytometric methods in the assessment of prognosis in transitional cell bladder cancer . Eur. Urol. , 21 : 177 – 183 .
   Google Scholar
• Otto , T , Birchmeier , W , Schmidt , U , Hinke , A , Schipper , J , Rubben , H and Raz , A . 1994 . Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas . Cancer Res. , 54 : 3120 – 3123 .
   PubMed Web of Science ®Google Scholar
• Bringuier , PP , Umbas , R , Schaafsma , HE , Karthaus , HF , Debruyne , FM and Schalken , JA . 1993 . Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors . Cancer Res. , 53 : 3241 – 3245 .
   PubMed Web of Science ®Google Scholar
• Shimazui , T , Schalken , JA , Giroldi , LA , Jansen , CF , Akaza , H , Koiso , K , Debruyne , FM and Bringuier , PP . 1996 . Prognostic value of cadherin-associated molecules (alpha-, beta- and gamma-catenins and p120cas . Cancer Res. , 56 : 4154 – 4158 .
   PubMed Web of Science ®Google Scholar
• Patel , DD , Wee , SF , Whichard , LP , Bowen , MA , Pesando , JM , Aruffo , A and Haynes , BF . 1995 . Identification and characterization of a 100 kD ligand for CD6 on human thymic epithelial cells . J. Exp. Med. , 181 : 1563 – 1568 .
   PubMed Web of Science ®Google Scholar
• Bowen , MA , Patel , DD , Li , X , Modrell , B , Malacko , AR , Wang , WC , Marquardt , H , Neubauer , M , Pesando , JM and Francke , U . 1995 . Cloning, mapping and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand . J. Exp. Med. , 181 : 2213 – 2220 .
   PubMed Web of Science ®Google Scholar
• Degen , WG , van Kempen , LC , Gijzen , EG , van Groningen , JJ , van Kooyk , Y , Bloemers , HP and Swart , GW . 1998 . MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule) . Am. J. Pathol. , 152 : 805 – 813 .
   PubMed Web of Science ®Google Scholar
• Van Kempen , LC , van den Oord , JJ , van Muijen , GN , Weidle , UH , Bloemers , HP and Swart , GW . 2000 . Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin . Am. J. Pathol. , 156 : 769 – 774 .
   PubMed Web of Science ®Google Scholar
• Tomita , K , van Bokhoven , A , Jansen , CF , Bussemakers , MJ and Schalken , JA . 2000 . Coordinate recruitment of E-cadherin and ALCAM to cell–cell contacts by alpha-catenin . Biochem. Biophys. Res. Commun. , 267 : 870 – 874 .
   Google Scholar
• Mostofi FK Sobin LH Torloni H 1973 Histological Typing of Urinary Bladder Tumors. International Classification of Tumors No. 10 World Health Organisation Geneva
   Google Scholar
• Hermanek P Sabin LH 1992 Union International Contre Cancer: TNM Atlas Springer-Verlag Berlin
   Google Scholar
• Schipper , JH , Frixen , UH , Behrens , J , Unger , A , Jahnke , K and Birchmeier , W . 1991 . E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis . Cancer Res. , 51 : 6328 – 6337 .
   PubMed Web of Science ®Google Scholar
• Umbas , R , Schalken , JA , Aalders , TW , Carter , BS , Karthaus , HF , Schaafsma , HE , Debruyne , FM and Isaacs , WB . 1992 . Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer . Cancer Res. , 52 : 5104 – 5109 .
   PubMed Web of Science ®Google Scholar
• Becker , KF , Atkinson , MJ , Reich , U , Becker , I , Nekarda , H , Siewert , JR and Hofler , H . 1994 . E-cadherin gene mutations provide clues to diffuse type gastric carcinomas . Cancer Res. , 54 : 3845 – 3852 .
   PubMed Web of Science ®Google Scholar
• Peltomaki , P and de la Chapelle , A . 1997 . Mutations predisposing to hereditary nonpolyposis colorectal cancer . Adv. Cancer Res. , 71 : 93 – 119 .
   PubMedGoogle Scholar
• Choi , S , Kobayashi , M , Wang , J , Habelhah , H , Okada , F , Hamada , J , Moriuchi , T , Totsuka , Y and Hosokawa , M . 2000 . Activated leukocyte cell adhesion molecule (ALCAM) and annexin II are involved in the metastatic progression of tumor cells after chemotherapy with Adriamycin . Clin. Exp. Metastasis , 18 : 45 – 50 .
   Google Scholar
• Kristiansen , G , Pilarsky , C , Wissmann , C , Stephan , C , Weissbach , L , Loy , V , Loening , S , Dietel , M and Rosenthal , A . 2003 . ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions . Prostate , 54 : 34 – 43 .
   Google Scholar
• Allard , P , Fradet , Y , Tetu , B and Bernard , P . 1995 . Tumor-associated antigens as prognostic factors for recurrence in 382 patients with primary transitional cell carcinoma of the bladder . Clin. Cancer Res. , 1 : 1195 – 1202 .
   PubMed Web of Science ®Google Scholar
• Ravery , V , Colombel , M , Popov , Z , Bastuji , S , Patard , JJ , Bellot , J , Abbou , CC , Fradet , Y and Chopin , DK . 1995 . Prognostic value of epidermal growth factor-receptor, T138 and T43 expression in bladder cancer . Br. J. Cancer , 71 : 196 – 200 .
   PubMed Web of Science ®Google Scholar